USFDA pulls up Intas Pharma for manufacturing lapses at Ahmedabad plant
The US health regulator has pulled up Intas Pharmaceuticals for manufacturing lapses, including violation of current good manufacturing practice
Continue reading
Tag: Indo-US trade